Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enovis Corporation Common Stock (NY:ENOV)

32.30 +0.59 (+1.84%)
Streaming Delayed Price Updated: 10:47 AM EDT, Sep 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Enovis Corporation Common Stock

< Previous 1 2 3 4 5 6 Next >
Enovis Above-Market Growth Potential Surge Would Come from Market Share Gains and Accretive Acquisitions: Analyst
Needham initiated coverage on Enovis Corp (NYSE: ENOV) with a Buy and a price target of $70, noting that the company can sustain above-market growth in its Reconstructive segment via market share gains... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023
 
Via Benzinga
Enovis to Participate in Investor Conferences in June
From Enovis Corporation
Via GlobeNewswire
3 Dividend Stocks That Are Raising Their Payouts
Earnings have been remarkably resilient despite higher prices. Here are three dividend stocks that are increasing payouts as a result. 
Via InvestorPlace
Looking Into Enovis's Return On Invested Capital
 
Via Benzinga
Enovis Beats Q1 Earnings Estimates, Raises 2023 Guidance
  
Via Benzinga
Enovis: Q1 Earnings Insights
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2023
 
Via Benzinga
Hyatt Hotels To Rally Over 26%? Here Are 10 Other Analyst Forecasts For Friday
Wells Fargo raised the price target for Enovis Corporation (NYSE: ENOV) from $55 to $67. Wells Fargo analyst Vik Chopra upgraded the stock from Equal-Weight to Overweight. Enovis shares rose 1.9% to... 
Via Benzinga
This Analyst With 83% Accuracy Rate Sees Around 11% Upside In Texas Roadhouse - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
U.S stocks closed higher on Friday, with the Dow Jones jumping more than 500 points during the session. 
Via Benzinga
Earnings Outlook For Enovis
 
Via Benzinga
Analyst Ratings for Enovis
Within the last quarter, Enovis (NYSE:ENOV) has observed the following analyst ratings: 
Via Benzinga
Enovis Announces First Quarter 2023 Results
From Enovis Corporation
Via GlobeNewswire
Enovis to Host First Quarter 2023 Results Conference Call on May 4th
From Enovis Corporation
Via GlobeNewswire
Enovis to Acquire Novastep
Strengthens Foot and Ankle Portfolio with Leading Minimally Invasive Surgery (MIS) Platform, including MIS Bunion System and Furthers Global Expansion Strategy 
From Enovis Corporation
Via GlobeNewswire
Top 5 Health Care Stocks That Preparing To Pump This Quarter
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Enovis Announces Board Leadership Transition
CEO Matt Trerotola to be named Chair and Director Sharon Wienbar to become Lead Independent Director following retirement of current Chair Mitchell P. Rales at 2023 Annual Meeting 
From Enovis Corporation
Via GlobeNewswire
ENOVIS™ Showcases Next Generation of Medical Technology at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting
Medtech Leader Highlights Power of Collaboration in Its Continued Success and Innovation 
From Enovis Corporation
Via GlobeNewswire
Newsweek Names Enovis™ as One of America’s Greatest Workplaces for Diversity 2023
From Enovis Corporation
Via GlobeNewswire
Enovis Announces Fourth Quarter and Full Year 2022 Results
From Enovis Corporation
Via GlobeNewswire
Enovis to Host Fourth Quarter and Full Year 2022 Conference Call on February 23rd
From Enovis Corporation
Via GlobeNewswire
Enovis™ to Showcase Latest Innovations and Growing Foot & Ankle Portfolio at ACFAS 2023
With innovative offerings spanning across foot and ankle indications, Enovis will highlight its latest products including knotless suture anchors, bone fixation systems and disruptive NiTiNOL... 
From Enovis Corporation
Via GlobeNewswire
Enovis Expands Foot & Ankle Portfolio’s DynaClip® Family by Introducing Procedure-Specific Staples
Innovative new staples combine strength with unmatched, sustained dynamic compression for mid-foot and first MTP joint fusions 
From Enovis Corporation
Via GlobeNewswire
Enovis to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From Enovis Corporation
Via GlobeNewswire
Enovis Receives FDA Approval of Patient Specific Instrumentation for STAR® Ankle
The approval of the STAR PSI System marks an impactful milestone by allowing surgeons to provide a personalized pre-operative plan for their total ankle replacement patients 
From Enovis Corporation
Via GlobeNewswire
Enovis Introduces DynaNail Helix™ – a New Twist on Hindfoot Fusions
Designed with our patented and proven NiTiNOL technology, DynaNail Helix™ revolutionizes dynamic compression in foot & ankle fusion 
From Enovis Corporation
Via GlobeNewswire
Enovis’ ARVIS® Awarded the AAHKS Industry Innovation Award at the 2022 American Academy of Hip and Knee Surgeons Annual Meeting
From Enovis Corporation
Via GlobeNewswire
Recap: Enovis Q3 Earnings
Enovis (NYSE:ENOV) reported its Q3 earnings results on Wednesday, November 2, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings Enovis beat estimated earnings by... 
Via Benzinga
Enovis Announces Third Quarter 2022 Results
From Enovis Corporation
Via GlobeNewswire
Enovis to Participate in Investor Conferences in November
From Enovis Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.